APG
MRK icon

Abacus Planning Group’s Merck MRK Stock Holding History

Abacus Planning Group’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.56M Sell
12,127
-1,139
-9% -$133K 0.19% 68
2026
Q1 		$1.6M Sell
13,266
-851
-6% -$98.2K 0.21% 62
2025
Q4 		$1.49M Buy
14,117
+862
+7% +$80.9K 0.2% 66
2025
Q3 		$1.11M Sell
13,255
-582
-4% -$47.9K 0.15% 77
2025
Q2 		$1.1M Sell
13,837
-498
-3% -$39.6K 0.16% 74
2025
Q1 		$1.29M Buy
14,335
+2,310
+19% +$216K 0.23% 61
2024
Q4 		$1.2M Buy
12,025
+47
+0.4% +$4.84K 0.21% 69
2024
Q3 		$1.36M Sell
11,978
-196
-2% -$23.3K 0.24% 60
2024
Q2 		$1.51M Buy
12,174
+1,116
+10% +$144K 0.29% 50
2024
Q1 		$1.46M Sell
11,058
-489
-4% -$60.3K 0.29% 48
2023
Q4 		$1.26M Sell
11,547
-544
-4% -$56.5K 0.27% 52
2023
Q3 		$1.24M Sell
12,091
-937
-7% -$101K 0.3% 47
2023
Q2 		$1.5M Buy
13,028
+1,004
+8% +$114K 0.36% 41
2023
Q1 		$1.28M Sell
12,024
-232
-2% -$25K 0.33% 50
2022
Q4 		$1.36M Buy
12,256
+1,019
+9% +$104K 0.37% 47
2022
Q3 		$968K Sell
11,237
-1,930
-15% -$172K 0.29% 56
2022
Q2 		$1.2M Sell
13,167
-872
-6% -$77.3K 0.35% 50
2022
Q1 		$1.15M Sell
14,039
-136
-1% -$10.7K 0.31% 58
2021
Q4 		$1.09M Buy
14,175
+2,053
+17% +$164K 0.29% 62
2021
Q3 		$910K Buy
12,122
+180
+2% +$13.7K 0.29% 63
2021
Q2 		$929K Sell
11,942
-738
-6% -$54.9K 0.28% 64
2021
Q1 		$933K Buy
12,680
+199
+2% +$14.7K 0.3% 64
2020
Q4 		$974K Sell
12,481
-167
-1% -$12.8K 0.3% 62
2020
Q3 		$1M Sell
12,648
-518
-4% -$40.6K 0.37% 54
2020
Q2 		$971K Buy
13,166
+268
+2% +$20.2K 0.4% 53
2020
Q1 		$947K Buy
12,898
+164
+1% +$12.9K 0.47% 43
2019
Q4 		$1.1M Sell
12,734
-424
-3% -$34.8K 0.51% 37
2019
Q3 		$1.06M Buy
13,158
+2,699
+26% +$216K 0.52% 39
2019
Q2 		$837K Hold
10,459
– – 0.5% 43
2019
Q1 		$830K Sell
10,459
-142
-1% -$10.6K 0.52% 44
2018
Q4 		$773K Buy
+10,601
New +$748K 0.59% 41

Other funds holding MRK

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Abacus Planning Group's MRK Position: Q2 2026 in Review

Abacus Planning Group reduced its Merck (MRK) stake by 8.6% in Q2 2026, selling an estimated $133K and leaving 12,127 shares worth $1.56M. The position accounts for 0.19% of the portfolio, ranked #68.

Abacus Planning Group first reported a position in MRK in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.6M in Q1 2026. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Abacus Planning Group held 12,127 shares of Merck worth $1.56M as of Q2 2026.
  • Abacus Planning Group sold 1,139 Merck shares in Q2 2026, an estimated $133K.
  • Merck made up 0.19% of Abacus Planning Group's portfolio in Q2 2026, its #68 holding.
  • Abacus Planning Group first reported a position in Merck in Q4 2018 and has held it in 31 quarters since.
  • Abacus Planning Group's Merck position peaked at $1.6M in Q1 2026.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Abacus Planning Group's 13F filing for Q2 2026, filed 20 Jul 2026.